Original Moxonidine and Generics: Where is the Edge of Difference?
V V SkibitskiyA V FendrikovaA V SkibitskiyD V SirotenkoO V Timofeeva
Published in: Kardiologiia (2024)
The treatment with original moxonidine demonstrated advantages over generic drugs in terms of achieving the BP goal, reducing office BP and HR, and improving 24-h BPM parameters.